Increased Survival after Treatment of Canine Hemangiosarcoma with Fenofibrate
<p>Hemangiosarcoma (HSA) is a common and highly metastatic tumor that affects predominantly large-breed dogs. The median survival time for dogs diagnosed with splenic HSA without adjuvant chemotherapy after surgery is 86 days. Fenofibrate is an FDA-approved drug commonly utilized to treat high...
Sparad:
Huvudskapare: | , , , , , |
---|---|
Materialtyp: | Bok |
Publicerad: |
International Journal of Veterinary Science and Research - Peertechz Publications,
2015-10-16.
|
Ämnen: | |
Länkar: | Connect to this object online. |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
Signum: |
A1234.567 |
---|---|
Exemplar 1 | Tillgänglig |